From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
about
MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR-γ agonist lowers triglyceride independently of PPAR-α activationSUMOylation of human peroxisome proliferator-activated receptor alpha inhibits its trans-activity through the recruitment of the nuclear corepressor NCoRRole of Glitazars in atherogenic dyslipidemia and diabetes: Two birds with one stone?Emerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerEcophysiology of omega Fatty acids: a lid for every jarPeroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications--a reviewInteraction of JAK with steroid receptor functionAlteration of energy substrates and ROS production in diabetic cardiomyopathyA Comprehensive and System Review for the Pharmacological Mechanism of Action of Rhein, an Active Anthraquinone IngredientBeta-carotene reduces body adiposity of mice via BCMO1Structural and Biochemical Basis for the Binding Selectivity of Peroxisome Proliferator-activated Receptor to PGC-1Revealing a steroid receptor ligand as a unique PPARγ agonistIdentification and Mechanism of 10-Carbon Fatty Acid as Modulating Ligand of Peroxisome Proliferator-activated ReceptorsIdentification of the antibiotic ionomycin as an unexpected peroxisome proliferator-activated receptor γ (PPARγ) ligand with a unique binding mode and effective glucose-lowering activity in a mouse model of diabetesCommonalities in the Association between PPARG and Vitamin D Related with Obesity and CarcinogenesisAlzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaAntitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gammaOmega-3 Fatty Acids and PPARgamma in CancerAdenosine A2A receptor modulates vascular response in soluble epoxide hydrolase-null mice through CYP-epoxygenases and PPARγCytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammationComparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytesTang-Nai-Kang alleviates pre-diabetes and metabolic disorders and induces a gene expression switch toward fatty acid oxidation in SHR.Cg-Leprcp/NDmcr ratsAdaptation of peroxisome proliferator-activated receptor alpha to hibernation in batsEnvironmental pollution: a tangible risk for NAFLD pathogenesisA compound-based proteomic approach discloses 15-ketoatractyligenin methyl ester as a new PPARγ partial agonist with anti-proliferative abilityPolymorphisms in PPAR Genes (PPARD, PPARG, and PPARGC1A) and the Risk of Chronic Kidney Disease in Japanese: Cross-Sectional Data from the J-MICC StudyComputational identification and experimental validation of PPRE motifs in NHE1 and MnSOD genes of human.Roles of PPARγ/NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy.Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.A concerted kinase interplay identifies PPARgamma as a molecular target of ghrelin signaling in macrophages.Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.Role of Peroxisome Proliferator-Activated Receptor (PPAR)δ in Embryonic Stem Cell Proliferation.Sex-different hepaticglycogen content and glucose output in rats.The pollutant diethylhexyl phthalate regulates hepatic energy metabolism via species-specific PPARalpha-dependent mechanismsDeficiency in the nuclear factor E2-related factor-2 transcription factor results in impaired adipogenesis and protects against diet-induced obesityTherapeutic Implications of Black Seed and Its Constituent Thymoquinone in the Prevention of Cancer through Inactivation and Activation of Molecular Pathways.In Silico Identification of Potent PPAR-γ Agonists from Traditional Chinese Medicine: A Bioactivity Prediction, Virtual Screening, and Molecular Dynamics Study.Epigenetic silencing of peroxisome proliferator-activated receptor γ is a biomarker for colorectal cancer progression and adverse patients' outcome.Alterations in lipid mediated signaling and Wnt/ β -catenin signaling in DMH induced colon cancer on supplementation of fish oil.
P2860
Q21342745-FBBE9AE0-5BA3-45FC-8572-CD8A672780C0Q24324236-2F5677DE-9AD8-4CDD-9F2B-BE9261DE2D08Q24564203-539EAEEB-9738-4567-B38A-3F734A1A2740Q26829126-14355990-60F6-49A5-B85D-51AAF7C1A4BCQ26859035-A2A5A9A8-5FC1-45FD-B345-C1C6AAC8F7C7Q26866784-F0F978A1-5341-45DD-B1C7-FAEC9BE41ADDQ26994082-328E8E95-08DE-4FC4-9C8C-C3786E4C622CQ27014882-0E7E2D56-3663-45B5-8D7F-F47C70384FBAQ27023870-318FA874-7BCA-41D4-B913-52D0CE920E48Q27336044-7A78E803-E1F8-450E-84F1-4A6673959C74Q27650576-2286982D-8655-4FBE-A3F5-00A2ABDC0548Q27674914-653B0409-D789-43E4-8A73-4788CDAAD94CQ27675297-5F3C7E96-DED7-48DF-B241-9E73F99D3269Q27683508-BB2D8F8F-ADA6-481C-AF69-A53C0EBEFE59Q28070220-73EABD08-3F6B-44C8-A166-61DF1020BF1AQ28075617-1FADA3A8-7DF2-49CB-AEF0-EB23A85F6647Q28251474-FAD66ABA-6FAC-4192-9943-E8C26C115339Q28292907-75A73169-D5FC-42CD-9B3A-B7613091945AQ28392991-635CDA20-5482-4689-9D2E-B8905209AA07Q28393303-13D469C7-64BD-4691-80B3-699E02901EA0Q28477796-7DCD2885-AC13-4A9A-93D9-8BE2BFC42C4BQ28546258-CDB3B063-D546-4AF4-82A5-39BECCD2B78EQ28647311-AFB7EE7B-1D71-4556-8080-C9500D62A2EFQ28661241-7E6B5DBC-DD41-462F-96AF-850DEF43DA74Q28818450-6AC53FD2-B4A0-4D62-BD41-65FB7D055081Q30704087-D7DCF583-68C5-473B-A165-D2318DB75708Q30951265-E606395C-43DB-4BF3-B899-013D2A00AF53Q31149202-2D112B5B-F9B4-4F7B-B886-3ABEFC41A6BCQ33496190-197DE84A-CDA8-477A-B97C-77093FD9A737Q33514871-EFFF0239-5AF8-46EE-BF82-0446EE37CF3AQ33583998-F73AD0C3-194D-4E29-A474-A126F82E4FABQ33585657-B9013AB4-13D1-4993-B48C-F881E3011AACQ33614818-0A9490A8-ED0A-4A30-854D-47C934DD33F0Q33701025-7938FDEF-17E8-4CC5-B8DA-E31962AFA74FQ33702683-A84A1B33-4001-45B9-9CCD-BDB8CA836C12Q33726669-140587CC-4EDB-480B-AA7C-713F236FC175Q33736242-F3F9CD8E-D0FA-4940-8EED-5A7E03DA85A2Q33757779-EE1E3299-5063-4326-9FCF-600C6B9F2849Q33769492-A707F3BA-01B6-4CFE-85C2-4DA2F813D999Q33791932-D2C02147-1319-4250-90CC-9B83023897CF
P2860
From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
From molecular action to physi ...... ads of key cellular functions.
@ast
From molecular action to physi ...... ads of key cellular functions.
@en
From molecular action to physi ...... ads of key cellular functions.
@nl
type
label
From molecular action to physi ...... ads of key cellular functions.
@ast
From molecular action to physi ...... ads of key cellular functions.
@en
From molecular action to physi ...... ads of key cellular functions.
@nl
prefLabel
From molecular action to physi ...... ads of key cellular functions.
@ast
From molecular action to physi ...... ads of key cellular functions.
@en
From molecular action to physi ...... ads of key cellular functions.
@nl
P2093
P1476
From molecular action to physi ...... ads of key cellular functions.
@en
P2093
Jérôme N Feige
Laurent Gelman
Liliane Michalik
Walter Wahli
P304
P356
10.1016/J.PLIPRES.2005.12.002
P577
2006-01-25T00:00:00Z